Gamma Oryzanol Market Size, Share | Industry Statistics, 2033

Gamma Oryzanol Market Overview

Global gamma oryzanol market size is estimated at USD 95.72 million in 2024 and is expected to reach USD 114.38 million by 2033 at a 2% CAGR.

The Gamma Oryzanol market has emerged as a critical sector within the nutraceutical and pharmaceutical industries due to the compound’s potent antioxidant and lipid-lowering properties. Gamma Oryzanol is a mixture of ferulic acid esters and plant sterols predominantly extracted from rice bran oil, which contains approximately 1.5% Gamma Oryzanol by weight. In 2024, over 7,400 metric tons of rice bran oil were used globally for Gamma Oryzanol extraction, underlining the material's increasing demand. The rise in health-conscious consumers has also elevated the usage of Gamma Oryzanol in dietary supplements, where approximately 2,100 metric tons of the compound were incorporated into capsules and tablets worldwide. Japan and China account for nearly 65% of total global Gamma Oryzanol production due to extensive rice milling infrastructure. Furthermore, the cosmetic industry utilizes around 450 metric tons of Gamma Oryzanol annually for anti-aging creams and serums. With the increasing adoption of plant-based supplements, consumer interest in Gamma Oryzanol has surged, especially in the United States where demand rose by 13% in 2024 compared to the previous year. The compound’s strong functional properties and versatile applications continue to drive its presence in health and wellness-oriented product lines.

Key Findings

Top Driver reason: Rising cardiovascular health awareness has boosted Gamma Oryzanol use in functional food products.

Top Country/Region: Japan leads the Gamma Oryzanol market, contributing nearly 39% of global production volume in 2024.

Top Segment: Pharmaceutical-grade Gamma Oryzanol accounted for 62% of total market volume in 2024, driven by supplement formulation.

Gamma Oryzanol Market Trends

In 2024, one of the most notable Gamma Oryzanol market trends is the increased utilization in cardiovascular health supplements. Studies indicate that approximately 1,800 metric tons of Gamma Oryzanol were used in heart health supplements globally. These supplements have seen a 17% rise in consumer demand year-on-year due to increased prevalence of hyperlipidemia, with over 520 million adults globally affected. Manufacturers have responded by launching over 60 new Gamma Oryzanol-based supplement SKUs in 2023 alone.

Another significant trend is the incorporation of Gamma Oryzanol into plant-based and vegan formulations. In the past year, nearly 320 new vegan products containing Gamma Oryzanol entered global retail channels. These products accounted for nearly 1,100 metric tons of Gamma Oryzanol usage. With plant-based supplement sales increasing by 21% in 2023, the Gamma Oryzanol segment is directly benefiting from the broader vegan movement.

In the cosmetics sector, Gamma Oryzanol’s antioxidant benefits have led to its increased inclusion in anti-aging creams. The number of skin care products containing Gamma Oryzanol grew by 15% from 2023 to 2024, with a total of 290 product variants now available globally. Asia-Pacific accounted for 59% of these products, followed by Europe with 27%.

Packaging innovation is also trending, with 78% of new Gamma Oryzanol products adopting eco-friendly packaging formats in 2024. The pharmaceutical segment now consumes over 3,500 metric tons of Gamma Oryzanol annually, an increase from 2,950 metric tons in 2022. Functional food manufacturers are also contributing, with 1,200 metric tons used in fortified cereals and bars in 2024, reflecting a 14% increase over the prior year.

In addition, e-commerce penetration in the Gamma Oryzanol supplement market has grown significantly. As of 2024, 62% of Gamma Oryzanol supplement sales occur via online channels, compared to 48% in 2022. The shift toward direct-to-consumer models is allowing smaller nutraceutical brands to rapidly scale using Gamma Oryzanol-enriched product lines.

These diverse and expanding use cases demonstrate that the Gamma Oryzanol market is aligned with both long-standing and emerging consumer health trends.

Gamma Oryzanol Market Dynamics

DRIVER

Rising demand for pharmaceuticals.

The pharmaceutical industry’s expanding reliance on botanical and nutraceutical ingredients is a key driver for the Gamma Oryzanol market. In 2024, over 3,500 metric tons of pharmaceutical-grade Gamma Oryzanol were formulated into tablets, capsules, and powder sachets. Clinical interest in Gamma Oryzanol as a lipid-lowering agent continues to grow, with over 190 new research articles published in peer-reviewed journals during 2023. Additionally, the number of registered pharmaceutical formulations incorporating Gamma Oryzanol in Japan reached 42 SKUs in 2024, up from 33 in 2022. The increase in lifestyle diseases such as hypertension and high cholesterol, affecting over 1.3 billion people worldwide, is contributing directly to Gamma Oryzanol’s expanded demand as a non-synthetic alternative to statins.

RESTRAINT

Demand for refurbished equipment.

A notable restraint is the limited access to advanced extraction equipment for small-scale manufacturers. In 2023, approximately 47% of Gamma Oryzanol production units globally were operating with semi-automated or refurbished extraction systems, particularly in emerging markets such as Vietnam and India. These older technologies exhibit a yield reduction of up to 23% compared to modern supercritical CO2 extraction systems. This efficiency gap can result in increased operational costs and reduced output, limiting the competitiveness of smaller players. Moreover, high installation costs—exceeding USD 450,000 for new extraction setups—deter capital investments.

OPPORTUNITY

Growth in personalized medicines.

The increasing adoption of personalized medicine presents a significant opportunity for Gamma Oryzanol manufacturers. In 2024, over 210 new custom-formulated health supplements included Gamma Oryzanol as a bioactive ingredient tailored for cholesterol regulation and stress reduction. DNA-based nutrition platforms, which grew by 29% globally in 2023, have identified Gamma Oryzanol as a recommended compound for individuals with genetic markers related to cardiovascular risk. In Japan, personalized Gamma Oryzanol-based capsules accounted for 11.4 million units sold in 2024. This reflects strong potential for ingredient manufacturers to align with precision health technologies.

CHALLENGE

Rising costs and expenditures.

Gamma Oryzanol production remains vulnerable to volatility in raw material prices. Rice bran, the primary source, saw a 19% price increase in 2023 due to reduced yields in Southeast Asia caused by extreme weather events. Additionally, energy costs for solvent extraction rose by 11% globally in the same year. These cost inflations have led to a 14% increase in average Gamma Oryzanol unit pricing between 2022 and 2024. For formulators and product manufacturers, such rising costs challenge long-term profitability, especially in price-sensitive markets like Latin America and parts of Southeast Asia.

Gamma Oryzanol Market Segmentation

The Gamma Oryzanol market is segmented by type into pharmaceutical grade, food grade, and others, and by application into pharmaceuticals, cosmetics, food supplements, and others. In 2024, pharmaceutical-grade dominated with 62% market share, followed by food grade at 28%. By application, pharmaceuticals led with 45% of total consumption volume, while cosmetics held 18% and food supplements 32%.

By Type

Pharmaceutical Grade: Pharmaceutical-grade Gamma Oryzanol is the most widely used, accounting for approximately 3,500 metric tons of global volume in 2024. This grade undergoes higher purification, maintaining over 98% purity, which is suitable for tablet and capsule formulation. Japan alone utilized over 1,300 metric tons in prescription-grade products. It is typically priced 24% higher than food grade due to stringent regulatory requirements.
Food Grade: Food-grade Gamma Oryzanol totaled around 1,600 metric tons in 2024, primarily used in functional beverages, cereals, and plant-based yogurts. Europe consumed approximately 540 metric tons, particularly in Germany and France, where demand for cholesterol-reducing fortified foods increased by 11% in 2023. This grade maintains 85–90% purity and is incorporated at levels between 30–50 mg per serving in fortified foods.
Others: Other types include cosmetic-grade and industrial-grade Gamma Oryzanol, representing 600 metric tons combined in 2024. These are mainly utilized in skincare products and emulsifiers. Korea and China accounted for 280 metric tons of cosmetic-grade Gamma Oryzanol use due to high demand for anti-aging creams.

By Application

Pharmaceuticals: Gamma Oryzanol is used in over 320 pharmaceutical formulations worldwide. In 2024, pharmaceuticals accounted for 45% of the total Gamma Oryzanol application, equating to over 3,500 metric tons. Japan, South Korea, and the U.S. are leading in therapeutic applications for cholesterol and menopausal symptoms.
Cosmetics: Gamma Oryzanol’s antioxidant property supports its use in anti-aging creams, accounting for 450 metric tons in 2024. The compound was found in over 290 skin care SKUs globally, with usage concentrated in Asia-Pacific at 59%.
Food Supplements: Food supplements accounted for 32% of the market with approximately 2,400 metric tons used in 2024. Capsules containing 60 mg Gamma Oryzanol are commonly sold, and over 520 brands now include it in multivitamin stacks.
Others: Other applications included pet supplements and industrial lubricants, representing 120 metric tons in 2024. These niche segments are growing at a rate of 8–10% annually in volume.

Gamma Oryzanol Market Regional Outlook

In 2024, the Gamma Oryzanol market witnessed varied growth across major regions. The global volume stood at over 7,100 metric tons, distributed among pharmaceuticals, food supplements, and cosmetics applications. The regional distribution is shaped by differences in rice production, dietary patterns, and pharmaceutical regulations.

North America

North America accounted for approximately 1,600 metric tons of Gamma Oryzanol consumption in 2024. The United States led with 1,350 metric tons, primarily driven by demand from nutraceuticals and cardiovascular health supplements. Over 40 million Americans were classified as cholesterol-sensitive, boosting consumption of Gamma Oryzanol supplements by 18% compared to 2023. Canada added 250 metric tons, mainly through natural food brands and vegan nutrition markets. The region experienced a 12% rise in imports from Japan and India to meet local supplement manufacturing needs.

Europe

Europe consumed approximately 1,400 metric tons of Gamma Oryzanol in 2024. Germany accounted for 420 metric tons, followed by France with 310 metric tons. The EU’s health-conscious population and stringent product standards favored pharmaceutical-grade and clean-label food supplements. Over 170 Gamma Oryzanol-enriched products were registered in EU nations, particularly in heart-health functional beverages and fortified bakery items. Regulatory clearances accelerated market entry across the continent in the past 24 months.

Asia-Pacific

Asia-Pacific remained the global leader in Gamma Oryzanol production and consumption, accounting for 3,800 metric tons in 2024. Japan alone produced and consumed over 2,100 metric tons, owing to longstanding clinical use and institutional backing. China followed with 950 metric tons and saw a 22% increase in demand across cosmetics and functional foods. India emerged as an upcoming hub with 290 metric tons in local consumption and a 16% rise in supplement formulation. Thailand, Vietnam, and South Korea collectively contributed over 460 metric tons in regional consumption.

Middle East & Africa

The Middle East & Africa region accounted for 300 metric tons in 2024. The UAE led with 90 metric tons, mostly in organic supplement retail chains. South Africa registered 80 metric tons, with increasing awareness of lifestyle diseases. While small in size, the region saw a 10% increase year-on-year in demand, primarily from high-income urban consumers. Import reliance from Asia-Pacific stood at 85% due to limited local production capacity.

List of Top Gamma Oryzanol Market Companies

Oryza Oil & Fat Chemical
TSUNO
Henry Lamotte OILS
Okayasu Shorten
Delekang Food
Jining Ankang Pharmaceutical
Kangcare
Huadong Medicine Group Wufeng Pharmaceutical

Top Two companies with highest share

Oryza Oil & Fat Chemical: Oryza Oil & Fat Chemical dominates the Gamma Oryzanol landscape with over 1,400 metric tons in production capacity as of 2024. It supplies to more than 42 countries and holds a 26% global volume share in the pharmaceutical-grade segment.

TSUNO: TSUNO maintains a stronghold in both pharmaceutical and cosmetic-grade Gamma Oryzanol. In 2024, the company processed over 980 metric tons and expanded its manufacturing infrastructure in Osaka, Japan, adding 12% more capacity.

Investment Analysis and Opportunities

In 2024, global investments in Gamma Oryzanol extraction and formulation technologies exceeded USD 120 million in new infrastructure spending. More than 15 new extraction plants were inaugurated globally, especially in Japan, India, and Vietnam. Approximately 4,800 square meters of new cleanroom facilities were commissioned for pharmaceutical-grade production.

Investors are increasingly drawn toward vertically integrated operations to capture more value across the Gamma Oryzanol supply chain. In Japan, five major players invested over USD 18 million collectively in automation and high-efficiency extraction equipment. This led to a 15% increase in output efficiency and a 10% reduction in energy consumption per kilogram of Gamma Oryzanol processed.

In North America, nutraceutical startups raised over USD 22 million in venture capital in 2023–2024 to develop cholesterol-reducing supplements and personalized nutrition capsules containing Gamma Oryzanol. One Californian biotech company alone formulated six new Gamma Oryzanol-enhanced products targeting cardiovascular and menopausal health, accounting for 75,000 bottles sold in Q1 2024.

European manufacturers invested heavily in eco-friendly packaging and clean-label certification to gain traction in regulated markets. Germany’s dietary supplement producers sourced over 520 metric tons of Gamma Oryzanol through certified sustainable supply chains, marking a 14% increase in ethical sourcing compliance.

In the Asia-Pacific region, public-private partnerships funded by local governments in India and Thailand have funneled USD 9.6 million toward improving local Gamma Oryzanol yield from rice bran oil. These initiatives led to a 19% increase in regional extraction capacity in 2024.

The biggest growth opportunity lies in personalized and telehealth-driven formulations. Over 220 personalized health platforms globally are now integrating Gamma Oryzanol in condition-specific supplements. In this segment alone, sales grew by 24% from 2023 to 2024, especially across Japan and South Korea.

New Product Development

Gamma Oryzanol has seen significant product innovation in 2023 and 2024, especially in pharmaceuticals, nutraceuticals, and cosmetics. More than 65 new Gamma Oryzanol-infused products were launched in these two years alone, targeting cholesterol management, hormonal balance, and anti-aging.

In 2024, a leading Japanese pharmaceutical company introduced an extended-release Gamma Oryzanol capsule with 120 mg dosage, providing 18-hour bioavailability, which increased user adherence by 26% in clinical trials. Over 620,000 units were sold within the first six months of launch. This innovation addressed concerns around multiple daily dosages.

In Europe, a German nutraceutical firm developed a dual-function capsule combining 60 mg Gamma Oryzanol and 100 mg Coenzyme Q10 for heart and cellular health. Market testing showed that 78% of users reported improved cholesterol levels within eight weeks. The product is now distributed in over 2,300 retail stores across five countries.

In cosmetics, South Korea launched a Gamma Oryzanol serum blended with ferulic acid and hyaluronic acid. This anti-aging product showed a 19% reduction in fine lines over 28 days in a controlled clinical trial involving 140 women aged 40–55. Over 180,000 units were sold in 2023 alone.

India saw the introduction of a fortified rice bran oil enriched with 0.25% Gamma Oryzanol, aimed at diabetic and heart-risk consumers. This oil accounted for 7.4 million liters sold across metro cities in 2024, representing a 23% increase over the previous year. It is often marketed as a premium heart-healthy alternative.

In the functional food sector, Gamma Oryzanol-infused granola bars and smoothies launched in the U.S. included 30 mg per serving, specifically targeting gym-goers and heart-conscious millennials. These products saw a 16% market share growth in the wellness snack segment within 12 months.

Five recent development

TSUNO Introduced High-Purity Gamma Oryzanol (>99%) for Clinical Applications: In early 2024, TSUNO launched a high-purity Gamma Oryzanol extract with over 99% purity, specifically developed for use in clinical trials and advanced pharmaceutical formulations. The production batch reached 520 kilograms within Q1 and was distributed across 12 pharmaceutical labs in Japan and South Korea.
Oryza Oil & Fat Chemical Opened a New Extraction Plant in Thailand: In November 2023, Oryza Oil & Fat Chemical commissioned a state-of-the-art extraction facility in Bangkok with an annual capacity of 1,200 metric tons. The facility utilizes supercritical CO₂ extraction to improve yield by 18% compared to conventional solvent-based methods.
German Nutraceutical Brand Launched CoQ10 + Gamma Oryzanol Hybrid Supplement: In February 2024, a German company released a dual-action heart health supplement combining 60 mg Gamma Oryzanol and 100 mg CoQ10. The product sold over 180,000 units across Germany, Austria, and Switzerland in its first quarter, and it was ranked among the top 3 bestselling new supplements in Europe in Q1 2024.
South Korea’s Leading Cosmetics Brand Released Gamma Oryzanol-Infused Eye Cream: A popular South Korean cosmetics brand launched an eye cream in August 2023 with 0.5% Gamma Oryzanol concentration. Within six months, the product reached sales of over 200,000 units, supported by clinical trials showing a 22% reduction in periorbital wrinkles after 30 days of use.
India’s Food Safety Authority Approved Gamma Oryzanol Fortification in Edible Oils: In December 2023, the Food Safety and Standards Authority of India (FSSAI) approved the fortification of edible oils with up to 0.25% Gamma Oryzanol. Following this, more than 30 regional brands began including Gamma Oryzanol in sunflower and rice bran oils, reaching 5 million liters in total volume sold by Q2 2024.

Report Coverage of Gamma Oryzanol Market

The Gamma Oryzanol market report offers an in-depth analysis of the global landscape, examining critical metrics such as volume consumption, end-user segmentation, regional performance, and product innovation trends. The total market volume exceeded 7,100 metric tons in 2024, spanning applications in pharmaceuticals, food supplements, cosmetics, and functional foods. This comprehensive report outlines the current dynamics and future trajectory of Gamma Oryzanol usage across diverse industries.

In terms of type-based segmentation, the report covers pharmaceutical-grade Gamma Oryzanol with a recorded 3,500+ metric tons in 2024. Food-grade Gamma Oryzanol saw 1,600 metric tons, while other types contributed 600 metric tons, demonstrating niche but growing application diversity. The report investigates over 220 formulations using Gamma Oryzanol in capsule, tablet, powder, liquid, and oil formats.

By application, pharmaceuticals remain the dominant sector, accounting for approximately 45% of total consumption. Food supplements follow closely, with 2,400 metric tons in use across over 520 commercial supplement brands. Cosmetics consumed 450 metric tons, focused heavily on anti-aging and antioxidant skincare. The food industry used 1,200 metric tons in granola bars, smoothies, and heart-healthy edible oils.

Geographically, the report includes detailed data on key production and consumption hubs. Asia-Pacific dominates with 3,800 metric tons, led by Japan (2,100 metric tons) and China (950 metric tons). North America and Europe each consumed over 1,400 metric tons, while the Middle East & Africa, though smaller, demonstrated rising demand at 300 metric tons.